Ameriprise
CELG

Ameriprise’s Celgene Corp CELG Stock Holding History

Ameriprise’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-535,704
Closed -$53.2M – 3842
2019
Q3 		$53.2M Sell
535,704
-30,632
-5% -$2.91M 0.02% 623
2019
Q2 		$52.4M Sell
566,336
-18,198
-3% -$1.73M 0.02% 652
2019
Q1 		$55.3M Sell
584,534
-1,823,648
-76% -$159M 0.03% 606
2018
Q4 		$154M Sell
2,408,182
-3,221,860
-57% -$238M 0.08% 268
2018
Q3 		$522M Sell
5,630,042
-644,250
-10% -$56.9M 0.18% 117
2018
Q2 		$497M Sell
6,274,292
-1,913,884
-23% -$159M 0.22% 90
2018
Q1 		$730M Sell
8,188,176
-1,785,649
-18% -$171M 0.33% 64
2017
Q4 		$1.04B Buy
9,973,825
+442,830
+5% +$50M 0.47% 36
2017
Q3 		$1.39B Sell
9,530,995
-343,219
-3% -$46.8M 0.66% 26
2017
Q2 		$1.28B Buy
9,874,214
+342,580
+4% +$42M 0.64% 26
2017
Q1 		$1.19B Sell
9,531,634
-161,655
-2% -$19.3M 0.61% 28
2016
Q4 		$1.12B Buy
9,693,289
+169,949
+2% +$18.9M 0.61% 28
2016
Q3 		$995M Sell
9,523,340
-1,517,649
-14% -$164M 0.56% 34
2016
Q2 		$1.09B Sell
11,040,989
-273,216
-2% -$28.3M 0.64% 30
2016
Q1 		$1.13B Buy
11,314,205
+372,741
+3% +$38.4M 0.68% 25
2015
Q4 		$1.31B Sell
10,941,464
-512,884
-4% -$59.3M 0.77% 20
2015
Q3 		$1.24B Buy
11,454,348
+706,078
+7% +$87.6M 0.77% 19
2015
Q2 		$1.24B Sell
10,748,270
-427,422
-4% -$48.9M 0.71% 18
2015
Q1 		$1.29B Sell
11,175,692
-828,270
-7% -$99M 0.74% 19
2014
Q4 		$1.34B Sell
12,003,962
-793,846
-6% -$83.7M 0.78% 15
2014
Q3 		$1.21B Buy
12,797,808
+53,534
+0.4% +$4.83M 0.73% 19
2014
Q2 		$1.09B Buy
12,744,274
+812,586
+7% +$61.8M 0.65% 20
2014
Q1 		$833M Sell
11,931,688
-297,328
-2% -$23.5M 0.5% 29
2013
Q4 		$1.03B Buy
12,229,016
+29,580
+0.2% +$2.34M 0.63% 18
2013
Q3 		$939M Buy
12,199,436
+955,606
+8% +$67M 0.62% 19
2013
Q2 		$657M Buy
+11,243,830
New +$677M 0.46% 35

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Ameriprise's CELG Position: Q4 2019 in Review

Ameriprise sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 535,704 shares — an estimated $53.2M sold.

Ameriprise first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.39B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ameriprise reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ameriprise sold 535,704 Celgene Corp shares in Q4 2019, an estimated $53.2M.
  • Ameriprise first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Ameriprise's Celgene Corp position peaked at $1.39B in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ameriprise's 13F filing for Q4 2019, filed 14 Feb 2020.